ஜர்னல் ஆஃப் நானோமெடிசின் & நானோடெக்னாலஜி

சுருக்கம்

Targeting Triple Negative Breast Cancer with a Small-sized Paramagnetic Nanoparticle

Li Zhang, Nadimpalli RS Varma, Zhang Z. Gang, James R. Ewing, Ali S Arbab and Meser M Ali

There is no available targeted therapy or imaging agent for triple negative breast cancer (TNBC). We developed a small-sized dendrimer-based nanoparticle containing a clinical relevant MRI contrast agent, GdDOTA and a NIR fluorescent dye, DL680. Systemic delivery of dual-modal nanoparticles led to accumulation of the agents in a flank mouse model of TNBC that were detected by both optical and MR imaging. In-vivo fluorescence images, as well as ex-vivo fluorescence images of individual organs, demonstrated that nanoparticles accumulated into tumor selectively. A dual modal strategy resulted in a selective delivery of a small-sized (GdDOTA)42-G4-DL680 dendrimeric agent to TNBC tumors, avoiding other major organs.